Rontalizumab - CISMeF

Preferred Label : Rontalizumab;

NCIt synonyms : Immunoglobulin G1, anti-(human interferons alpha type); humanized mouse monoclonal rhuMAB IFNalpha gamma1 heavy chain (des-CH3(sup 107)K, CH1(sup 97)R K-IGHG1*03) (220-218')-disulfide with humanized mouse monoclonal rhuMAB IFNalpha kappa light chain, dimer (226-226'':229-229'')-bisdisulfide; RhuMAb IFNalpha;

UNII : LDO2FIQ61I;

CAS number : 948570-30-7;

Détails

Origin ID

C95794;

UMLS CUI

C2987428;

Currated CISMeF NLP mapping
- rontalizumab [MeSH concept]
- rontalizumab [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- rontalizumab [MeSH Supplementary Concept]
- rontalizumab [MeSH concept]
chemical_or_drug_has_mechanism_of_action
- Antigen Binding [NCIt concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients